Clinical Trial Detail

NCT ID NCT03325101
Title Dendritic Cell Therapy After Cryosurgery in Combination With Pembrolizumab in Treating Patients With Stage III-IV Melanoma That Cannot Be Remove by Surgery
Recruitment Recruiting
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Mayo Clinic
Indications

melanoma

Therapies

Pembrolizumab

Age Groups: adult senior

No variant requirements are available.